nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of dendritic cells by targeted DNA: a potential addition to the armamentarium for anti-cancer immunotherapy
|
Fyrstenberg Laursen, Marlene |
|
2019 |
68 |
11 |
p. 1875-1880 |
artikel |
2 |
Adhering to adhesion: assessing integrin conformation to monitor T cells
|
Gouttefangeas, Cécile |
|
2019 |
68 |
11 |
p. 1855-1863 |
artikel |
3 |
Adhering to adhesion: assessing integrin conformation to monitor T cells
|
Gouttefangeas, Cécile |
|
|
68 |
11 |
p. 1855-1863 |
artikel |
4 |
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation
|
Schwartz, Anthony L. |
|
2019 |
68 |
11 |
p. 1805-1817 |
artikel |
5 |
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope
|
Martinenaite, Evelina |
|
2019 |
68 |
11 |
p. 1901-1907 |
artikel |
6 |
CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models
|
Bogen, Bjarne |
|
2019 |
68 |
11 |
p. 1865-1873 |
artikel |
7 |
Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer
|
Park, Yujun |
|
2019 |
68 |
11 |
p. 1779-1790 |
artikel |
8 |
Contribution of Fcγ receptor IIB to creating a suppressive tumor microenvironment in a mouse model
|
Kasahara, Yuki |
|
2019 |
68 |
11 |
p. 1769-1778 |
artikel |
9 |
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine
|
Lapenta, Caterina |
|
2019 |
68 |
11 |
p. 1791-1804 |
artikel |
10 |
Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation
|
Bialek-Waldmann, Julia K. |
|
2019 |
68 |
11 |
p. 1891-1899 |
artikel |
11 |
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy
|
Tarone, Lidia |
|
2019 |
68 |
11 |
p. 1839-1853 |
artikel |
12 |
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
|
Heeren, A. Marijne |
|
2019 |
68 |
11 |
p. 1759-1767 |
artikel |
13 |
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy
|
Sakellariou-Thompson, Donastas |
|
2019 |
68 |
11 |
p. 1747-1757 |
artikel |
14 |
Schwann cells shape the neuro-immune environs and control cancer progression
|
Martyn, German V. |
|
2019 |
68 |
11 |
p. 1819-1829 |
artikel |
15 |
The challenges of adoptive cell transfer in the treatment of human renal cell carcinoma
|
Strizova, Zuzana |
|
2019 |
68 |
11 |
p. 1831-1838 |
artikel |
16 |
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer
|
Sofopoulos, Michael |
|
2019 |
68 |
11 |
p. 1733-1745 |
artikel |
17 |
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy
|
Spear, Timothy T. |
|
2019 |
68 |
11 |
p. 1881-1889 |
artikel |